Ethics in Publishing
Conflict of Interest
Competing Interests
Submitting Related Manuscripts
Copyright and Licensing
Patient confidentiality
Copyright transfer
The waiver policy for developing country authors
Advertising policy
The Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern
Preparing the manuscript for submission
Title page
Structure of the text
Abbreviations in text


Our Dermatology Online – GENERAL INFORMATION

Our Dermatology Online journal is a medical journal publishing original scientific papers based on authorial research, as well as review and opinion articles and case studies. The Advisory Board includes specialists from many countries around the world. Our Dermatology Online journal is quarterly and is available in electronic form at Papers are published in English, with abstracts and key words in this languages. It is acceptable to articles written in any other language, with a compulsory summary in English. The editors of Our Dermatology Online journal endorse the principles embodied in the Helsinki Declaration (reference) and expect that all research involving humans has been performed in accordance with these principles. For animal experimentation reported in the journal, it is expected that investigators will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences’ Adhoc Committee on Animal Research. All human and animal studies must have been approved by the chief investigator’s institutional review board. Authors are requested to include a copy of the relevant documentation with the submitted manuscript. 
  • The whole process of submission of the manuscript to final decision and sending/receiving proofs as well is completed online.

Peer review in all its forms plays an important role in ensuring the integrity of the scholarly record. The process depends to a large extent on trust, and requires that everyone involved behaves responsibly and ethically. Peer reviewers play a central and critical part in the peer-review process, but too often come to the role without any guidance and may be unaware of their ethical obligations. The COPE Ethical Guidelines for Peer Reviewers set out the basic principles and standards to which all peer reviewers should adhere during the peer-review process.
Received manuscripts are first examined by the Our Dermatology Online journal. 
Manuscripts are evaluated according to the following criteria: material is original, writing is clear, study methods are appropriate, data are valid, conclusions are reasonable and supported by the data, and information is important and interesting. 
Manuscripts clearly not suitable for publication are rejected and returned to the first author without further review. Incomplete work or manuscripts not prepared in the required style (see below) will be sent back to the authors without scientific review, but may be resubmitted as soon as they have been corrected. The first author will notified e-mail when the manuscript is registered at the Editorial Office, and the registration number will be indicated. The responsible editor will make the decision either to send the manuscript to another reviewer to resolve the difference of opinion or return it to the authors for revision. The ultimate decision to accept, accept subject to correction, or reject a manuscript lies within the prerogative of the of the Editor-in-Chief and is not subject to appeal. 
Manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential. The existence of a manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. Peer reviewers are required to maintain confidentiality about the manuscripts they review and must not divulge any information about a specific manuscript or its content to any third party without prior permission from the journal editors. Information from submitted manuscripts may be systematically collected and analyzed as part of research to improve the quality of the editorial or peer review process. Identifying information remains confidential. Reviews and decisions on manuscripts in which the editor or an associate editor is a coauthor are managed independently by an associate editor or editor from another institution. Final decisions regarding manuscript publication are made by the Editor, who does not have any financial relationships with any biomedical company.
For the evaluation of each publication shall be appointed at least two independent reviewers from outside the unit. Authors and reviewers do not know their identity (?single-blind review proces?). Review must end with an explicit request for approval to publish the article or its rejection. Once a year the journal shall publish a list of reviewers co-operating in web.
Ethics in Publishing
We abide by Code of Conduct by Committee on Publication Ethics (COPE) and aim to adhere to its Best Practice Guidelines.
Authors are expected to be aware of, and comply with, best practice in publication ethics, specifically with regard to authorship, dual submission, plagiarism, manipulation of figures, competing interests, and compliance with standards of research ethics.
In cases of suspected or alleged misconduct, we will follow COPE standards and practices and may seek advice from the COPE forum if needed.
Publication Ethics and Publication Malpractice Statement. As part of the efforts to improve the quality of the journal, we would like to emphasize the importance of maintaining high ethical standards when publishing articles in Our Dermatol Online:
  1. Articles submitted to Our Dermatol Online must not contain any results that have been reported in any journals or books in any form. The articles must be authentic and should not contain manipulated data or fraudulent information and must not contain any results that have been, or will be, submitted to other journals. This also applies to direct translation between different languages.
  2. Our Dermatol Online requires that the submitted manuscript is solely from the author?s own work and not from the work of others, unless explicit permission has been granted. This includes text, figures and tables. Information from published articles must always be cited explicitly. Proper citation is to give the credit to the work that is originally published, not to follow-up work or reviews. Citations should be given close to the information within the sentences or at the end of the sentence, not after several sentences or near the end of the paragraph. Even when citations are given, exact copying of a whole sentence or paragraphs should be indicated by quotation marks. Furthermore, re-use of part of a published figure or table requires a copyright permission from the publishers that hold the rights. All re-published figures and tables should explicitly indicate the original source.
  3. Articles should describe results as accurately as possible, and avoid using statements of opinions as if they are facts. The manuscript should present the results in a direct way and avoid misleading or misunderstanding. It is important to discuss the significance of the results; at the same time, it is crucial not to over-interpret the results. Excessive or biased interpretation will not contribute to scientific progress and will mislead readers.
  4. Articles should present a balanced perspective through proper citation of relevant literature in the field, rather than a biased view. Although it is reasonable to favor a specific interpretation over others, it is important to consider opposing or competing hypotheses. Even when a postulate is supported by more convincing evidence or greater amount of data than others, alternative possibilities that cannot be eliminated should be discussed. Consideration of various possibilities does not weaken the conclusions, but offer the readers a more comprehensive understanding of the issue.
  5. To be considered an author, the person in question should have made direct and meaningful contributions to the article, should have contributed to one or more of the following aspects: (1) coordination of the research project, (2) design of the research plan, (3) carrying out experimentation and (4) data analysis. It is the corresponding authors? responsibility to seek the permission from each author to publish the materials and to get consensus on the authorship before submitted to Our Dermatol Online.
In summary, academic misconduct in any form will not be tolerated in Our Dermatol Online. In cases of suspected misconduct (plagiarism, fraud, breached intellectual property rights, etc.) a panel will be formed to evaluate the substance of the claim. If the claim is supported by evidence, the paper in question will be rejected for consideration in Our Dermatol Online and all authors and their affiliations will be informed. In cases where the paper has already been published before the misconduct was discovered, a retraction by authors or by Our Dermatol Online board will have to take place and the case will be made public. Evident cases of misconduct may result in a three-year or longer ban from future submission to Our Dermatol Online. All appeals regarding the panel?s decisions have to go via Editor-in-Chief and should be submitted within 30 days from the decision date.
Conflict of Interest 
Each author must indicate on the Conflict of Interest Disclosure Form whether they have financial, equity, patenting or other relevant relationships or arrangements with a product or sponsor of research that might constitute a conflict of interest. More information on conflict of interest can be found on the form and in The Uniform Requirements for Manuscripts Submitted to Biomedical Journals, by the International Committee of Medical Journal Editors. Sources of support or declared conflicts should be indicated under a separate heading entitled 'Conflict of Interest,’ between the Materials & Methods and References sections. If the authors have nothing to declare, this should be noted using the standard phrase, „The authors state no conflict of interest.”
Upon submission, the corresponding author must submit a Declaration of Conflict of Interest form signed by all authors, with signatures identified. A manuscript with number will be mailed to the corresponding author same day or within 24 hours. Upon acceptance, the Corresponding Author will be asked to provide the editorial office with the text of the final, accepted manuscript in a Word (.doc) or other document file and one complete set of publication-quality figures as well as an Artwork and Supplementary Materials form. Failure to provide these materials will result in a delay in publication.
Competing Interests
Authors, editors, reviewers, and commenters must all declare any potential competing interests related to any manuscript they are involved with. Author declaration of competing interests When submitting a paper, the corresponding author is asked to declare, on behalf of all authors, whether there are any financial, personal, or professional interests that could be construed to have influenced the paper.
Authors must declare any and all potential competing interests involving people or organizations that might be perceived as relevant. Submissions with incomplete or incorrect declarations of competing interests may be rejected.
Our Dermatology Online journal expects that authors of articles will not have any financial interest in a company (or its competitor) that makes a product discussed in the article, or in a competitive company. Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product is discussed in the submitted manuscript. Manuscripts will not be sent to reviewers from the same institution as the authors.
„Ghostwriting”, „guest authorship” is a manifestation of scientific misconduct, and any detected cases will expose, including notifying the appropriate entities.
Submitting Related Manuscripts
When submitting an article, authors must confirm that the manuscript (or any related manuscript) has not been submitted and is not under consideration or accepted elsewhere. If related work has been submitted elsewhere, then authors must include a copy with the submitted article. Reviewers will be asked to comment on the overlap between related submissions.
Copyright and Licensing
Open access agreement. Upon submitting an article, authors are asked to indicate their agreement to abide by an open access Creative Commons license (CC-BY). Under the terms of this license, authors retain ownership of the copyright of their articles. However, the license permits any user to download, print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work. The license ensures that the authors’ article will be available as widely as possible and that the article can be included in any scientific archive.
Materials taken from other sources must be accompanied by a written statement from both the first author and the publisher of the original publication in which the materials appeared, giving permission for reproduction in Our Dermatology Online journal. Permission should be obtained in writing from at least one author of papers still in press, and from the primary sources of unpublished data and personal communications.
Patient confidentiality
Changing the biographical details of patients in order to disguise their identity amounts to tampering with data and should be discouraged. However, the authors of clinical papers are obliged to protect their patients’ right to privacy. Only clinically or scientifically important data are permitted for publishing. Therefore, if the text or illustrations of an article make it possible to determine or infer the identify of a patient, the authors must supply the written consent of the patient or guardian to publish his/her data, including photographs and radiological images, prior to publication. Details of the race, ethnicity, religion, or cultural background of a study subject should be mentioned only when it is believed to have an impact on the course of the disease and/or treatment discussed in the study.
Copyright transfer
Upon acceptance, the authors transfer copyright to Editor Our Dermatology Online journal. Upon acceptance for publication, all submitted materials become the permanent property of Editor Our Dermatology Online journal, the publisher of Our Dermatology Online journal. However, the license permits any user to download, print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work
Every effort is made by the Publisher and Editorial Board to see that no inaccurate or misleading data, opinions, or statements appear in Our Dermatology Online journal. However, the contents of the articles and advertisements are ultimately the responsibility of the contributor, sponsor or advertiser concerned. Accordingly, the Publisher and the Editorial Board accept no liability whatsoever for the consequences of any such inaccurate of misleading data, opinion or statement.
Scientific Reports keeps all details about a submitted manuscript confidential and does not comment to any outside organization about manuscripts that are either under consideration or that have been rejected.
Plagiarism is when an author attempts to pass off someone else’s work as his or her own. Duplicate publication, occurs when an author reuses substantial parts of his or her own published work without providing the appropriate references. This can range from getting an identical paper published in multiple journals, where authors add small amounts of new data to a previous paper. Plagiarism can be said to have clearly occurred when large chunks of text have been cut-and-pasted. Such manuscripts would not be considered for publication in Scientific Reports. But minor plagiarism without dishonest intent is relatively frequent, for example, when an author reuses parts of an introduction from an earlier paper.
The name of the piece of software that you use to detect plagiarism: Grammarly and Quetext
The waiver policy for developing country authors 

We encourage our authors living in developing countries to publish their papers with us.
A range of discounts or waivers are offered to authors, for example on fast-track submission.


Advertising policy

Advertising policy

The Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern

The Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of Concern



CATEGORIES OF ARTICLES NEW- since issue 3.2018  (July 2018)
Manuscripts submitted for publication should be clearly identified as belonging to one of the following categories:
Original Articles
Articles reporting the previously unpublished results of completed scientific experiments conducted by the authors, confirming or refuting a clearly defined research hypothesis.
Original articles should be organized as follows: Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Conflict of Interest, Acknowledgments, References. 
-text 3000 words (but ODO will accept 4000 words for qualitative articles or mixed methods articles involving a qualitative element)
-?9 tables and/or figures
-abstract of no more than 350 words using the headings listed: Background; Material and Methods; Results; Conclusions.
-references not less than 15;

The Clinical Trials as original articles within the Journal:

-In general, we recommend that clinical trial manuscripts are prepared in original article format, but for small studies it may be more appropriate to consider submission as a Research Letter or Brief Report.
-All clinical trials must conform to appropriate ethical standards and must have been approved by the relevant ethical committees and authors? and institutional review board(s). A statement to this effect with the exact name of the approving institutional review board(s) should be included in the Materials and methods section. All clinical investigations must be conducted according to the principles expressed in the Declaration of Helsinki.
-Submissions reporting industry-sponsored clinical trials are welcomed. The ODO recommends that all authors, particularly those reporting industry-sponsored clinical trials, take account of the guidelines of Mansi et al. when preparing their manuscript (Mansi BA, Clark J, David FS et al. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mayo Clin Proc 2012; 87:424?9).
-Reporting of randomized controlled trials must follow the CONSORT statement to assure completeness. In order to facilitate manuscript review, a completed CONSORT checklist should be submitted at the same time as the manuscript, identified as a ?Supplementary file for review?. For randomized controlled trials with specific designs, data or interventions, please refer to the extensions of the CONSORT statement. For pilot and feasibility studies, please refer to the CONSORT extension for these studies.
-Even for nonrandomized trials the CONSORT statement, or another appropriate EQUATOR guideline, should be followed as closely as possible. The reporting of systematic reviews and meta-analyses should follow the PRISMA statement. Reporting of meta-analyses and systematic reviews on observational studies should follow the MOOSE consensus statement (see attachment).
Brief Reports
Short papers of investigations (e.g., descriptive studies) in health sciences organized in the same manner as full-length articles.
-which contain 1000-1500 words or less (from introduction through discussion),
-with no more than 3 tables and/or figures,
-abstract of no more than 150 words using the headings listed: Background; Material and Methods; Results; Conclusions.

-up to 20 references;


Case Reports
Reports of 1 or 3 complicated or unique cases. Articles describing in detail the diagnosis and/or treatment of 1-3 patients, emphasizing unusual or difficult features of therapy in the case(s) described, within the thematic scope of Our Dermatology Online journal. Reports a new information not readily available in textbooks for the continuing medical education. Case reports should be of especial interest not only for the journal but for the dermatology in the world.
From issue 2021 January (issue 1.2021), case reports will only be accepted exceptionally. 
-text 800-1300 words.
-limited of tables / figures no more than 6.
-abstract should include a unstructured abstract of no more than 150 words (but not less than 80) using the data: Background, Case Report, Conclusion. (The headers listed apply only when submitting articles to the Editorial Office and no longer show up during publication). 

-references are limited to 20;


Review Articles Articles presenting the current state of knowledge on a given issue, with emphasis on current controversies, theoretical and practical approaches to the problem, etc., including a well chosen bibliography.
-a Review Article is normally 3,000?5,000 words (excluding Abstract and references).
-abstract 150 words

-references no limited (but not less than 20).

Opinion Articles Oescriptions of important issues, controversies, and opinions in the area of dermatology
-2000 words (or 1700 words with 1 table or 1 figure);
-short, unstructured abstract

-not less than 15 references.

Case Letters / Obsesrvation Letters

May report original data or present hypotheses.

Contain very short case reports. Acceptance is contingent on editorial review. Observations are formatted with introductory sentences, followed by the following headings: Report of a Case and Discussion. Allowed a brief Introduction

-letters are not to exceed 600 words
-1-3 figures or tables, or no more than 2 pages in pdf file.
-letters should not have an abstract.

not more than 7 references.

Research Letters / Study Letters / Therapy Letters Their main purpose is to create an opportunity to publish preliminary research findings which may lead on to more substantial research studies. Manuscripts should be concise, thought-provoking and of general interest. Examples include: phase 1 clinical trials; pilot studies whose aim is to test research methodology; the generation of preliminary data to inform subsequent study design; small observational or experimental studies; retrospective clinical or pathological series from single institutions; studies which confirm or extend what has recently been published by others; studies which add to the collective understanding of a topic without being sufficiently novel or significant in themselves to justify an original article; studies which use a single research method, where two or three complimentary methods would be the norm for an original article.
-research letters should not exceed 850 words.
-0-3 figures or three tables.
-research letters should have no abstract.

-10 references,


Clinical Images / Histopathological Images

Photographic descriptions of interesting or unusual clinical, radiologic, or pathologic phenomena. Organize the manuscript as follows: Title Page, Description, Figure(s) and References (optional). The main manuscript should be written in the format of a clinical vignette. Start with a short introduction followed by the case description including pertinent history, physical examination, clinical work-up, and outcome, as applicable.

From 02.2023 „Our Dermatology Online” publishes articles like (Clinical Image) only 4 per year.
Therefore, the Clinical Image articles sent to us will undergo a very restrictive screening.
For authors sending articles of the Clinical Image type, we offer publications in the Online Section or publication in a book published once a year.

-should be limited to 300 words description,
-0-3 references;

„Textbook” type submissions are discouraged. 


Others: From 02.2023 „Our Dermatology Online” publishes articles like (item types from the list below) only in the Online Section.  
Practical issues Practical issues on the medical topics

-with figures and/or tables.

Discussion Letters discussing a recent article in this journal should be submitted within 4 weeks of the article’s publication in print. 
-400 words;
-?6 references (1 of which should be to the recent article);

-?3 authors

Perspectives Provide an opinion. Articles should be concise, thought-provoking.
-should not exceed of 750 words;
-one figure orone small table

-6 references,.

Opinion Pieces As an item of correspondence are also welcome; original ideas, innovations, scholarly opinions, debates and controversies at an early stage of academic development.
-they should not exceed 400 words
-one figure.

– 6 references

Historical articles Presentation of important figures, movements, and advances in the field of dermatology.
-abstract 150 words

-not less than 5 references.

Commentary – Comment tho the Article Commentaries are written on invitation of the Editors, and narrowly focused on the articles published by the journal. They provide critical or alternative viewpoints on key issues and generally consist of a discussion of an article published in the journal.

-references are limited to 1-2

What is your diagnosis?

 in only online section – Our Cases

This section explores a case report in which the final diagnosis of the disease is questioned.
It should include the following topics: Case report; Discussion; References.
Allowed a brief Introduction.
Net Articles

Articles may be submitted for online publication only (not regular issue). The author should inform the reaction about it at the time of submitting the manuscript. The entire articlewill be available online at the journal site:


All items of correspondence should be formatted in one continuous section, with no bulleted statements or abstract. They can be published online or printed at the discretion of the editors.

The following instructions are in general compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (N Eng J Med 1997;336: 309-15;
All authors should accept (Ethical Requirements for Studies Involving live human subjects or animal).
Accepting involves collecting and sending the file along with the article for the editorial e-mail.
Preparing the manuscript for submission
The work should be sent by e-mail address:
The text should be written in a 12-point font with one-and-a-half spacing and margins of 2.5 cm (1 inch) on all four sides, in Word. The editors reserve the right to edit the article for formatting.
Title page
The manuscript should have a title page containing the following information:
  • the full name of each author, 
  • the organizational affiliation of each author (workplace),
  • ORCID number (if the author has)
  • the full title of the article in both English or in addition to any other language, in which work be written.
  • 3-6 key words selected in accordance with the MeSH system as used in the Index Medicus (MEDLINE),
  • the first author’s full name, address, telephone and/or fax number, and e-mail address if available, for purposes of correspondence during the preparation of the manuscript for print,
  • the sources of any material or financial support, in the form of grants, subventions, major donations, etc., if any.
Regardless of the language in which the work is submitted, the article will be accompanied by summaries in English in addition to any other language, in which work be written. If the manuscript is submitted with a summary only in the original language, it is a precondition for publication that the missing summary be supplied. The summaries should have similar structure and content in both languages.
The summary for Original Articles and Brief Report should be in structured form, not exceeding 350 words, and should consist of four paragraphs of 1-3 sentences each, labeled:
Background: the purpose of the article or research, the primary thesis.
Material and Methods: a brief description of the research; in the case of a review or opinion article, a characterization of the literature; for a case study, a brief description of the patient; the main parameters measured, etc.
Results: the most significant results achieved.
Conclusions: the most important 1-2 conclusions derived by the authors from the results presented in the article. The preceding structure does not apply in detail to review or opinion articles.
Abstract in Case Report should include a unstructured abstract of no more than 150 words using the data: Background, Case Report, Conclusion.
Abstract in Review Articles and Historical Articles include a nonstructured abstract of no more than 150 words.
Structure of the text
The text of the article should be divided into six sections labeled: Introduction, Material and Methods, Results, Discussion, Conclusions, References. Before References, if appropriate, the authors may insert Acknowledgements; an Appendix may be attached at the end, if needed. Each section should be clearly designated by a title in boldface.
When circumstances require, depending on the contents and nature of the article, a different structure may be used, provided, however, that the structure of the article is clear, transparent and self-consistent.
Introduction should give the scientific and/or clinical rationale for researching the given topic, the primary issues and controversies, an explanation of the aim of the study and the primary thesis.
Material and methods should contain essential information regarding how the experiment or research was conducted, including the essential characteristics of the experimental and control groups (age, gender), inclusion and exclusion criteria, and the randomization and masking (blinding) method used. The protocol of data acquisition, procedures, investigated parameters, methods of measurements and apparatus should be described in sufficient detail to allow other scientists to reproduce the results. In the case of published methods, the names with appropriate references should be given. References and a brief description should be provided for methods that have been published but are not well known, whereas new or substantially modified methods should be described in detail. The rationale for using such new or unknown methods should be discussed, along with a balanced evaluation of these methods, not omitting their limitations. Drugs and other chemicals should be precisely identified, including the generic name, dosage, and route of administration.
Information regarding the patients’ informed consent should be included in the text of the article (see above: Patient confidentiality). Study subjects should be identified only by arbitrarily assigned initials or numbers. Any information contained in photographs, images, or other illustrations that could serve to reveal the person’s identity should be thoroughly camouflaged or concealed. The faces of persons appearing in photographs should be masked or covered with a black band, unless for compelling reasons this is impossible.
Results concisely and reasonably summarize the findings in the form of text, tables and figures arranged in a logical and internally self-consistent manner. The number of tables and figures should be limited to those absolutely needed to confirm or refute the thesis. Data given in graphs and tables should not be automatically repeated in the text. The number of observations should be clearly indicated, as well as exclusions or losses to observation. Any complications that may occur in treatment or examination should be reported.
Discussion should deal only with new and/or important aspects of the results obtained, without repeating in detail data or other material previously presented in Introductions or Results. The Discussion should focus on the theoretical implications and/or practical consequences of the findings, including suggestions for further research. The Discussion should compare the results of the present study to those obtained by other investigators mentioned in the text.
Conclusions must be linked with the goals of the study. New hypotheses with recommendations for further research should be advanced only when fully warranted and explicitly justified. Include recommendations when appropriate. Unqualified statements and conclusions not supported by the data obtained should be avoided.
Acknowledgements list all those who have contributed to the research but do not meet the criteria for authorship, such as assistants, technicians, or department heads who provided only general support. Financial and other material support should be disclosed and acknowledged.

Since January 2018For authors writing in a language other than English.

1. Articles written in Spanish, French and other languages

Articles (original articles, case reports, review articles) will be published only with Abstracts in English, key words in English and descriptions (legends) under figures / tables in English. This also applies to other types of articles: clinical / histopathological images, letters…).

2. Articles written in other languages than English

Articles that will be written in languages other than English will not be published in regular editions (issueus). It is allowed to publish these articles in the Supplements or „Online Section” in planned or fast-track mode.


Chosen for their importance and accessibility, are numbered consecutively in the order of their occurrence in the text. Number of cited references is not limited. References first cited in tables or figure legends must be numbered in such a way as to maintain numerical sequence with the references cited in the text. Identify footnotes in text by Arabic numerals in square brackets; they should appear like the following: [1,2,5,6] or [3-8]. The style of references, which will be strictly observed, is that of Index Medicus. When an article has six or fewer authors, all should be listed; when there are seven or more, only the first six are listed, then ?et al.?
The following sample references are taken from the Uniform Requirements for Manuscripts Submitted to American Medical Association Manual of Style (
Standard journal article
1. Shelley WB, Shelley ED. Coexistent erythrasma, trichomycosis axillaris, and pitted keratolysis: an overlooked corynebacterial triad? J Am Acad Dermatol. 1982;7:752-7.
2. Abreu Velez AM, Jackson BL, Velasquez Cantillo KL, Rafael A, Alvarez B, Howard MS. Merkel cell carcinoma versus metastatic small cell primary bronchogenic carcinoma. Our Dermatol Online. 2013;4:64-71.
3. Ajili F, Bousseta N, Msakni I, Metoui L, Gharsallah I, Laabidi J, et al. Symptomatic macroglossia and tongue myositis in Dermatomyositis. Our Dermatol Online. 2013;4:176-8.
Article in electronic form
Drayer DE, Koffler D:. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5];1(1):[24 screens]. Available from: URL:
Book, personal author(s)
Ringsven MK: Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
Book, editor(s) as author
Barankin B, Metelista AI, Lin AN: Illustrated Dictionary of Dermatology Eponyms. LWW, Baltimore 2005.
Chapter in a book
Sokołowska-Wojdyło M, Placek W: Receptory TCR ? rearan?acja genów, [w:] Pierwotne chłoniaki skóry. M. Sokołowska-Wojdyło, J. Roszkiewicz (red.), Wydawnictwo Czelej, Lublin. 2008: 45-51.
Conference proceedings
Kimura J, Shibasaki H, editors: Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam. Elsevier. 1996.
Abstracts or reviews should generally not be cited as references, nor should ?unpublished observations? or ?personal communications?. If such material is necessary, it should be incorporated and acknowledged in the text at the appropriate place.
are numbered consecutively in the order of their first citation in the text, with a brief title. A short or abbreviated heading should be used for each column. Descriptions of the table should be prepared both in English and also in any other language in which the work is written. The arrangement of the table should be as simple as possible, without adding unnecessary horizontal or vertical subdivisions. Explanations, including the clarification of non-standard abbreviations, should be provided in footnotes under the table, and not in the table itself. The footnotes should be numbered independently for each table. Figures should be professionally done; freehand or typewritten lettering is unacceptable. Titles and detailed explanations should be given in the legends, not on the illustrations themselves.
should be numbered consecutively according to the order in which they are first cited in the text. Care should be taken that each figure is in fact mentioned in the text. It is recommended that color photographs. Photomicrographs should have internal scale markers. The symbols, arrows, or letters used in photomicrographs should contrast with the background. If photographs of people are used, either the identity should be masked. In other cases it must be accompanied by a statement of consent signed by the patient.
Identify tables by Roman numerals accompanied by an appropriate caption. Figure and table captions shal by in your language and English.
Identify figures by Arabic numerals, whereas tables by Roman ones. Tables, figures, drawings and photographs may be processed using any mode and software (*.jpg, *.tif, *.bmp).
Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury.
All hematological and clinical chemistry measurements should be reported in the metric system in a manner consistent with the International System of Units (Sl). Alternative or non-Sl units should be added in parentheses.
Abbreviations in text
The specialist abbreviations shall be provided for the first time with a full name in brackets and then on their own in the text.
Manuscript should accompany the letter. This letter should include:
Authors of the paper are obliged to confirm they hold copyright. A declaration pertaining to the status of the work, including the fact that it has to not been previously published. After publication shall transfer all copyrights to the Editorial Office of „Our Dermatology Online?. Only paper abstracts are allowed to be published without any prior consent of the Publisher. Authors who use materials from other publications are obliged to have a written consent to using them, signed by their authors or publisher. The Publisher bears no responsibility for the content of papers and advertisements.
It is with great joy that we announce transitioning from a print journal to an electronic-only journal. Starting from 1st of January 2020, Our Dermatology Online will no longer be issuing print copies of the journal. All new and archived published articles can be accessed from our website at:

Our Dermatology Online is an Open Access Journal and all articles can be accessed through our website free of charge.

Fast-track submission


The journal is completely free. Fees only at the author’s request in the case of: Fast-track submission, both in regular editions and in ONLINE SECTION.
ATTENTION: The journal may send information about the NATIVE SPEAKER correction to the author ! This is the only such situation (except Fast-track submission) where the author may incur fees!
All the materials should be sent to the editor by e-mail:






ODO Publishing House
ul. Orlat Lwowskich 2,
76-200 Slupsk,
tel. 48 692 121 516,
fax. 48 59 815 18 29

Comments are closed.